Findings from extended study in patients with CAD
HOST-EXAM Extended study: Clopidogrel monotherapy had lower discontinuation rate (8% vs. 13.5%), reduced risk of death, MI, stroke, ACS readmission, and bleeding. Long-term clopidogrel use preferred for CAD secondary prevention.